<?xml version="1.0" encoding="UTF-8"?>
<p id="Par102">The use of aerosol ribavirin and pavilizumab as preventive strategies in patients with URTI evolving in LRTI is still debated, especially in lymphopenic patients [
 <xref ref-type="bibr" rid="CR48">48</xref>].
</p>
